Randomized Phase III Study to Evaluate the Efficacy and Safety of Xyzal® (Levocetirizine) vs Zyrtec® (Cetirizine) in Subjects With Dermatitis and Eczema

PHASE3CompletedINTERVENTIONAL
Enrollment

466

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions
DermatitisEczema
Interventions
DRUG

Levocetirizine

1 Levocetirizine 5mg tablet per day before bedtime for 14 days

DRUG

Cetirizine

1 Cetirizine 10mg tablet per day before bedtime for 14 days.

DRUG

Placebo-Levocetirizine

1 Placebo-Levocetirizine tablet per day before bedtime for 14 days

DRUG

Placebo-Cetirizine

1 Placebo-Cetirizine tablet per day before bedtime for 14 days

DRUG

Standard topical steroid (1% hydrocortisone) ointment

1% hydrocortisone ointment, applied 2-3 times a day to all affected areas

Trial Locations (3)

Unknown

Gyeunggi-do

Kyeonggi-Do

Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

UCB Pharma

INDUSTRY